Back
Atossa Therapeutics Stock Price Chart

Pacaso, now reserving Nasdaq ticker PCSO, is offering shares at $2.80 until May 29.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.*Pacaso recently received their ticker reservation with Nasdaq
Buy
53
ATOS
Atossa Therapeutics
Last Price:
$0.83
Seasonality Move:
-0.51%
7 Day Trial
ALL ACCESS PASS
$
7

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
The current trend is moderately bearish and ATOS is experiencing slight selling pressure.
Atossa Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.94 | Sell |
20-day SMA: | 0.87 | Sell |
50-day SMA: | 0.75 | Buy |
200-day SMA: | 1.07 | Sell |
8-day EMA: | 0.91 | Sell |
20-day EMA: | 0.87 | Buy |
50-day EMA: | 0.81 | Buy |
200-day EMA: | 0.97 | Sell |
Atossa Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 53.04 | Buy |
Chaikin Money Flow: | -95721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.72 - 0.94) | Buy |
Bollinger Bands (100): | (0.69 - 0.91) | Buy |
Atossa Therapeutics Technical Analysis
May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Atossa Therapeutics Stock
Is Atossa Therapeutics Stock a Buy?
-
Atossa Therapeutics share price is 0.87 while ATOS 8-day simple moving average is 0.94, which is a Sell signal.
-
The stock price of ATOS is 0.87 while Atossa Therapeutics 20-day SMA is 0.87, which makes it a Sell.
-
Atossa Therapeutics 50-day simple moving average is 0.75 while ATOS share price is 0.87, making it a Buy technically.
-
ATOS stock price is 0.87 and Atossa Therapeutics 200-day simple moving average is 1.07, creating a Sell signal.
ATOS Technical Analysis vs Fundamental Analysis
Buy
53
Atossa Therapeutics (ATOS)
is a Buy
Is Atossa Therapeutics a Buy or a Sell?
-
Atossa Therapeutics stock is rated a BuyThe current Atossa Therapeutics [ATOS] share price is $0.87. The Score for ATOS is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
Atossa Therapeutics Stock Info
Market Cap:
112.4M
Price in USD:
0.87
Share Volume:
617.6K
Atossa Therapeutics 52-Week Range
52-Week High:
1.66
52-Week Low:
0.55
Buy
53
Atossa Therapeutics (ATOS)
is a Buy
Atossa Therapeutics Share Price Forecast
-
What is the Atossa Therapeutics stock price today?The Atossa Therapeutics stock price is 0.87 USD today.
-
Will ATOS stock go up or go down?Atossa Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Atossa Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atossa Therapeutics is not overvalued.
Is Atossa Therapeutics Stock a Buy?
-
Atossa Therapeutics share price is 0.87 while ATOS 8-day exponential moving average is 0.91, which is a Sell signal.
-
The stock price of ATOS is 0.87 while Atossa Therapeutics 20-day EMA is 0.87, which makes it a Buy.
-
Atossa Therapeutics 50-day exponential moving average is 0.81 while ATOS share price is 0.87, making it a Buy technically.
-
ATOS stock price is 0.87 and Atossa Therapeutics 200-day simple moving average is 0.97, creating a Sell signal.
Fundamental Analysis of Atossa Therapeutics
Is Atossa Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Atossa Therapeutics
Should I short Atossa Therapeutics stock?
-
ATOS Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Atossa Therapeutics is a Buy
-
Atossa Therapeutics Relative Strength Index (RSI) is 53.04, which suggest Atossa Therapeutics is overbought
-
The Bollinger Bands (25) for Atossa Therapeutics is (0.72 - 0.94), which suggest Atossa Therapeutics is a Buy
-
The Bollinger Bands (100) for Atossa Therapeutics is (0.69 - 0.91), which suggest Atossa Therapeutics is a Buy
* Atossa Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.